Potential Strategies to Control the Risk of Antifungal Resistance in Humans: A Comprehensive Review

• Váldodahkkit: Ali A. Rabaan (Dahkki), Tarek Sulaiman (Dahkki), Shamsah H. Al-Ahmed (Dahkki), Zainab A. Buhaliqah (Dahkki), Ali A. Buhaliqah (Dahkki), Buthina AlYuosof (Dahkki), Mubarak Alfaresi (Dahkki), Mona A. Al Fares (Dahkki), Sara Alwarthan (Dahkki), Mohammed S. Alkathlan (Dahkki), Reem S. Almaghrabi (Dahkki), Abdulmonem A. Abuzaid (Dahkki), Jaffar A. Altowaileb (Dahkki), Maha Al Ibrahim (Dahkki), Eman M. AlSalman (Dahkki), Fatimah Alsalman (Dahkki), Mohammad Alghounaim (Dahkki), Ahmed S. Bueid (Dahkki), Awad Al-Omari (Dahkki), Ranjan K. Mohapatra (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: MDPI AG, 2023-03-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Fungal infections are becoming one of the main causes of morbidity and mortality in people with weakened immune systems. Mycoses are becoming more common, despite greater knowledge and better treatment methods, due to the regular emergence of resistance to the antifungal medications used in clinical...